Archives
-
Shh, Fgf10 and Fgfr2 in Species-Specific Penile Development
2026-08-15
The 2025 Cells study compares guinea pig and mouse genital tubercle development to explain why the two species form the penile urethra differently. Its combination of spatial expression analysis, quantitative PCR, and ex vivo protein or inhibitor perturbation implicates differential Shh and Fgf10/Fgfr2 signaling in urethral groove and prepuce morphogenesis.
-
BKT140 (BL-8040) CXCR4 Antagonist
2026-08-14
BKT140, also called BL-8040 and TF 14016, is an orally bioavailable CXCR4 antagonist for oncology and hematopoietic stem cell research. It blocks CXCR4-linked migration and survival biology while supporting assays of tumor behavior and blood-cell mobilization.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-14
Track mRNA entry and EGFP expression in the same mammalian cell with a dual-readout reporter built for delivery optimization. This practical workflow connects fluorescence microscopy, flow cytometry, and lipid nanoparticle characterization while separating uptake from productive translation.
-
Phosphatase Inhibitor Cocktail 2 for Phospho-State Fidelity
2026-08-13
Phosphatase Inhibitor Cocktail 2 supports protein phosphorylation preservation from tissue collection through Western blot and immunoprecipitation. This guide uses puerarin-driven metabolic signaling research to show how inhibitor selection, sampling discipline, and assay controls determine the reliability of phosphoprotein conclusions.
-
Protease Inhibitor Cocktail for Reliable Assays
2026-08-13
This scenario-based guide explains how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1007, can protect labile proteins during lysate preparation without introducing EDTA into phosphorylation-sensitive workflows. It also separates appropriate post-lysis use from direct cell-viability applications and provides practical selection, dilution, storage, and interpretation guidance.
-
Drug Response Metrics in Cancer In Vitro
2026-08-12
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different relationships between growth inhibition and cell death. The framework supports more informative drug-response experiments by pairing proliferation and killing endpoints across treatment time rather than relying on a single viability value.
-
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-08-12
Protect phosphorylation-dependent biology from the moment of lysis through Western blot, co-IP, imaging, and kinase assays. This practical guide combines a 1:100 dosing workflow with assay-specific troubleshooting and a SIRT6 proteostasis case study.
-
Obeticholic Acid: FXR Workflows for Fibrosis
2026-08-11
Obeticholic Acid enables controlled FXR activation across hepatocyte, cholestasis, inflammation, and fibrosis workflows. This guide connects practical dosing and assay design with the Notch and NK-cell findings from a recent liver fibrosis study, while clearly separating established product biology from exploratory translational extensions.
-
IGF2BP1–TUBB4B Axis in HSC Activation
2026-08-11
The reference study identifies an m6A-dependent IGF2BP1/TUBB4B/FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. By integrating transcriptomic and RNA-binding data with molecular and cellular validation, it connects RNA modification-dependent mRNA stabilization to liver fibrogenesis and suggests a framework for testing pathway-directed interventions.
-
GmMKK4–GmMPK6–GmERF113 Drives Soybean Immunity
2026-08-10
The reference study identifies a phosphorylation-dependent GmMKK4–GmMPK6–GmERF113 cascade that strengthens soybean resistance to Phytophthora sojae. Its genetic, biochemical, and transcriptional evidence connects pathogen-induced MAPK activity with ERF113 stabilization and activation of GmPR1 and GmPR10-1, providing a mechanistic framework for soybean disease-resistance research.
-
Phosphatase Inhibitor Cocktail: Workflow Guide
2026-08-09
Protect phosphorylation-dependent biology from harvest through immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry with a dual-component inhibitor strategy. This guide explains sequential tube addition, assay-specific controls, and troubleshooting for more reproducible phosphoprotein measurements.
-
Phosphatase Inhibitor Cocktail 3 in ER-Phagy Assays
2026-08-08
Phosphatase Inhibitor Cocktail 3 helps preserve transient phosphorylation during lysate preparation. This guide connects phosphoprotein analysis with Salmonella-driven ER-phagy research and explains how to design better controls, extraction workflows, and mechanistic readouts.
-
Lambda Protein Phosphatase for BMAL1 Phase Separation
2026-08-07
Lambda Protein Phosphatase provides a practical causal test for phosphorylation-dependent BMAL1 condensate behavior. This article connects λ-PPase treatment, antibody validation, and phase-separation assays while defining controls and interpretation limits.
-
Polygodial as a TRPA1 Channel Activator: Protocols & Innovat
2026-08-07
Polygodial enables precise and reproducible modulation of TRPA1 channels for advanced sensory neuron and membrane transporter signaling studies. This guide translates the latest reference findings into actionable workflows, troubleshooting tactics, and strategic assay design, distinguishing APExBIO’s Polygodial as an essential research compound.
-
TRIM66 Controls Olfactory Receptor Monogenic Expression in O
2026-08-06
This study identifies TRIM66 as a crucial epigenetic repressor orchestrating the precise 'one-neuron-one-receptor' rule in olfactory sensory neurons. The findings provide mechanistic insight into how monogenic olfactory receptor expression is achieved, with implications for understanding sensory coding and broader gene regulation principles.